18 September 2020 : Original article
ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients – Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
Shih-Chao Hsu123ABCDEF, Ashok Thorat13ABCEF, Long-Bin Jeng143ABCDEF*, Ping-Chun Li135ADF, Te-Hung Chen123BCF, Horng-Ren Yang123BDE, Kin-Shing Poon36DFDOI: 10.12659/AOT.923502
Ann Transplant 2020; 25:e923502

Figure 6 Survival analysis comparing ABO-i LDLT and ABO-compatible LDLT patients.